Calithera Biosciences, Inc. Gains 150%
Mon, Apr 15, 2024 at 07:19 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) jumped higher at $0.05, a gain of 150%. On Mon, Apr 15, 2024, CALA:NASDAQ hit a New 2-Week High of $0.05. From Mon, Apr 01, 2024, the stock recorded 33.33% Up Days and 14.29% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- Unico American Corporation (UNAM:NASDAQ), 357.58%
- SRAX, Inc. (SRAX:NASDAQ), 203.51%
- Movella Holdings Inc Com (MVLA:NASDAQ), 177.78%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 150%
- Longeveron Inc. (LGVN:NASDAQ), 73.37%
- Hub Cyber Security Ltd. (HUBC:NASDAQ), 50%
- Kuke Music Holding Limited American Depositary Shares each representing one (KUKE:NYSE), 47.95%
- SuperCom Ltd. (SPCB:NASDAQ), 45.07%
- StoneBridge Acquisition Corporation (APAC:NASDAQ), 43.03%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 38.89%